
|Videos|June 28, 2017 (Updated: January 4, 2022)
Could SBRT Have Role in Metastatic Kidney Cancer?
Author(s)Thomas Schwaab, MD, PhD
This video examines a pilot trial that tested stereotactic body radiotherapy plus nephrectomy in patients with renal cell carcinoma.
Advertisement
In this video, Thomas Schwaab, MD, PhD, of Roswell Park Cancer Institute in Buffalo, New York, discusses a pilot trial that tested stereotactic body radiotherapy (SBRT) plus nephrectomy in patients with renal cell carcinoma.
The
Video courtesy of
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Related Content
Advertisement


Comparable Ipilimumab/Nivolumab Outcomes Observed in Older RCC Population
Published: | Updated:



Advertisement
Advertisement
Trending on CancerNetwork
1
Dato-DXd/Durvalumab Shows Promising Outcomes in Advanced TNBC
2
GLP-1 Receptor Agonists in Breast Cancer: 5 Key Clinical Takeaways
3
Ultra-Hypofractionation Proves Feasible in Locally Advanced Breast Cancer
4
What Were the Top 2026 ACSO Genitourinary Symposium Abstracts?
5



















































